Expression of Iron Transporters and Pathological Hallmarks of Parkinson’s and Alzheimer’s Diseases in the Brain of Young, Adult, and Aged Rats
暂无分享,去创建一个
Y. Ke | Z. Qian | W. Yung | Lina Lu | Ka-Chun Wu
[1] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[2] I. Chaudry,et al. Kinetics of glucose uptake in isolated soleus muscle. , 1969, Biochimica et Biophysica Acta.
[3] J. Gutteridge. Antioxidant properties of caeruloplasmin towards iron‐ and copper‐dependent oxygen radical formation , 1983, FEBS letters.
[4] J. Connor,et al. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.
[5] J. Connor,et al. Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.
[6] J. Connor,et al. Iron in the brain. , 2009, Nutrition reviews.
[7] J. Connor,et al. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain , 1993, The Journal of comparative neurology.
[8] J. Connor,et al. Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging , 1994, Journal of neurochemistry.
[9] Jim Mintz,et al. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI , 1994, Biological Psychiatry.
[10] B. Gelman,et al. Iron in CNS Disease , 1995, Journal of neuropathology and experimental neurology.
[11] J. Gitlin,et al. Increased plasma lipid peroxidation in patients with aceruloplasminemia. , 1996, Free radical biology & medicine.
[12] J. Connor,et al. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains , 1997, Neuroscience.
[13] Z. Qian,et al. Brain iron and neurological disorders. , 1997, Chinese medical journal.
[14] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] F. Ye,et al. Increasing striatal iron content associated with normal aging , 1998, Movement disorders : official journal of the Movement Disorder Society.
[16] O. Rascol,et al. Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study , 1998, Movement disorders : official journal of the Movement Disorder Society.
[17] E. Hirsch,et al. Iron metabolism and Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.
[18] Z. Qian,et al. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders , 1998, Brain Research Reviews.
[19] D. Inzitari,et al. Parkinson’s disease and parkinsonism in a longitudinal study , 2000, Neurology.
[20] N. Andrews,et al. Disorders of iron metabolism. , 1999, The New England journal of medicine.
[21] D. Inzitari,et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. , 2000, Neurology.
[22] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[23] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[24] D. Berg,et al. Brain iron pathways and their relevance to Parkinson's disease. , 2001, Journal of neurochemistry.
[25] Z. Qian,et al. Brain iron transport and neurodegeneration. , 2001, Trends in molecular medicine.
[26] Y. Ke,et al. Rethinking the role of ceruloplasmin in brain iron metabolism , 2001, Brain Research Reviews.
[27] M Gallorini,et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.
[28] T. Rouault,et al. Iron on the brain , 2001, Nature Genetics.
[29] Y. Ke,et al. Distribution of Ferroportin1 Protein in Different Regions of Developing Rat Brain , 2002, Developmental Neuroscience.
[30] Ya Ke,et al. Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.
[31] C. Levenson,et al. Iron and ageing: an introduction to iron regulatory mechanisms , 2004, Ageing Research Reviews.
[32] D. Price,et al. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.
[33] S. M. Sadrzadeh,et al. Iron and brain disorders. , 2004, American journal of clinical pathology.
[34] K. Jellinger. Lewy body-related alpha-synucleinopathy in the aged human brain. , 2004, Journal of neural transmission.
[35] K. Jellinger. Lewy body-related α-synucleinopathy in the aged human brain , 2004, Journal of Neural Transmission.
[36] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[37] Y. Ke,et al. Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain , 2005, Neurobiology of Aging.
[38] Y. Ke,et al. Effects of development and iron status on ceruloplasmin expression in rat brain , 2005, Journal of cellular physiology.
[39] J. Connor,et al. Is ferroportin–hepcidin signaling altered in restless legs syndrome? , 2006, Journal of the Neurological Sciences.
[40] O. von Bohlen und Halbach,et al. Distribution of the iron‐regulating protein hepcidin in the murine central nervous system , 2006, Journal of neuroscience research.
[41] T. Ganz,et al. Regulation of iron metabolism by hepcidin. , 2006, Annual review of nutrition.
[42] J. Kordower,et al. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? , 2007, Neurobiology of Disease.
[43] W. Rayens,et al. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys , 2007, Neurobiology of Aging.
[44] Y. Ke,et al. Development and iron‐dependent expression of hephaestin in different brain regions of rats , 2007, Journal of cellular biochemistry.
[45] Ya Ke,et al. Brain iron metabolism: Neurobiology and neurochemistry , 2007, Progress in Neurobiology.
[46] Y. Ke,et al. Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart. , 2007, Biochimica et biophysica acta.
[47] Z. Qian,et al. Amyloid β‐peptide 31–35‐induced neuronal apoptosis is mediated by caspase‐dependent pathways via cAMP‐dependent protein kinase A activation , 2008 .
[48] Y. Ke,et al. Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. , 2008, Endocrinology.
[49] Z. Qian,et al. Amyloid beta-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation. , 2008, Aging cell.
[50] G. Perry,et al. Getting the iron out: phlebotomy for Alzheimer's disease? , 2009, Medical hypotheses.
[51] Z. Qian,et al. Role of hepcidin in murine brain iron metabolism , 2009, Cellular and Molecular Life Sciences.
[52] Y. Ke,et al. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. , 2009, The Journal of nutritional biochemistry.
[53] G. Ying,et al. Age-dependent and gender-specific changes in mouse tissue iron by strain , 2009, Experimental Gerontology.
[54] Naftali Raz,et al. A Systems Approach to the Aging Brain: Neuroanatomic Changes, Their Modifiers, and Cognitive Correlates , 2009 .
[55] N. Schröder,et al. mRNA Expression of Proteins Involved in Iron Homeostasis in Brain Regions is Altered by Age and by Iron Overloading in the Neonatal Period , 2010, Neurochemical Research.
[56] Sunil K. Kakarla,et al. Aging-Associated Dysfunction of Akt/Protein Kinase B: S-Nitrosylation and Acetaminophen Intervention , 2009, PloS one.
[57] Douglas Galasko,et al. Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers , 2011, NeuroMolecular Medicine.
[58] Dean Y. Li,et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. , 2010, The Journal of clinical investigation.
[59] A. Planas,et al. In vitro and in vivo activation of astrocytes by amyloid-beta is potentiated by pro-oxidant agents. , 2010, Journal of Alzheimer's disease : JAD.
[60] Jim Mintz,et al. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. , 2010, Journal of Alzheimer's disease : JAD.
[61] Rachel L. Mistur,et al. Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's , 2010, Biological Psychiatry.
[62] J. Trojanowski,et al. In Vivo Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders , 2011, The Journal of Neuroscience.
[63] K. Lim,et al. Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T α-Synuclein , 2011, The Journal of Biological Chemistry.
[64] Tomas Ganz,et al. Hepcidin and iron regulation, 10 years later. , 2011, Blood.
[65] Y. Ke,et al. Neuroprotective effect of ligustilide against ischaemia‐reperfusion injury via up‐regulation of erythropoietin and down‐regulation of RTP801 , 2011, British journal of pharmacology.
[66] Y. Ke,et al. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP‐protein kinase a pathway , 2011, Glia.
[67] Miaozong Wu,et al. Effect of aging on cellular mechanotransduction , 2011, Ageing Research Reviews.
[68] D. Surmeier,et al. Physiological phenotype and vulnerability in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.
[69] Robert Zivadinov,et al. Brain iron accumulation in aging and neurodegenerative disorders , 2012, Expert review of neurotherapeutics.
[70] Blaine R. Roberts,et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.
[71] M. Núñez,et al. Iron toxicity in neurodegeneration , 2012, BioMetals.
[72] Bin Wang,et al. Regulation of iron-related molecules in the rat hippocampus: sex- and age-associated differences. , 2012, Annals of clinical and laboratory science.
[73] C. Franceschi,et al. Inflamm-ageing , 2013, Current opinion in clinical nutrition and metabolic care.
[74] Gunnar Brunborg,et al. Metal Dyshomeostasis and Inflammation in Alzheimer's and Parkinson's Diseases: Possible Impact of Environmental Exposures , 2013, Oxidative medicine and cellular longevity.
[75] Ana M. Daugherty,et al. Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis , 2013, NeuroImage.
[76] Y. Ke,et al. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease , 2014, Neurobiology of Aging.
[77] A. Dale,et al. What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus , 2014, Progress in Neurobiology.
[78] D. Turnbull,et al. Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?☆ , 2014, Ageing Research Reviews.
[79] Y. Ke,et al. Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway , 2014, Molecular Neurobiology.